|
|
Volumn 350, Issue 9074, 1997, Pages 370-371
|
|
Good manners for the pharmaceutical industry.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
PACLITAXEL;
DRUG INDUSTRY;
FEMALE;
HUMAN;
NOTE;
OVARY TUMOR;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CISPLATIN;
DRUG INDUSTRY;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 85044706087
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)63432-0 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
